News Conference News TCT 2016 Novel SES Fails to Match Xience EES for Chronic Total Occlusions Yael L. Maxwell November 08, 2016
News Conference News TCT 2016 RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent Michael O'Riordan November 08, 2016
News Conference News TCT 2016 No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low Shelley Wood November 07, 2016
News Conference News TCT 2016 ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions L.A. McKeown November 07, 2016
News Industry News TCT 2016 Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions November 02, 2016
Presentation TCT 2016 RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso November 02, 2016
Presentation TCT 2016 How to Treat BRS Restenosis (With Case Examples) Presenter: Ashok Seth, Pieter C. Smits November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice! Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller November 01, 2016
Presentation TCT 2016 TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small Vessel Disease: Insights From the Nanoluté Registry Presenter: Germano Di Sciascio, Bruno Scheller November 01, 2016
Presentation TCT 2016 Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up Presenter: Fernando Alfonso, Ran Kornowski, Pieter R. Stella November 01, 2016
Presentation TCT 2016 Nanoparticle Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis: Results from the Nanolute Registry Presenter: Fernando Alfonso, Ran Kornowski, Bernardo Cortese November 01, 2016
News Conference News TCT 2016 New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts Yael L. Maxwell October 31, 2016
Presentation TCT 2016 Case Resolution: How Did We Treat this Patient? Presenter: Nick Curzen, Michael Mahmoudi October 31, 2016
Presentation TCT 2016 TAVR Restenosis: Review of the Literature Presenter: Nick Curzen October 31, 2016
Presentation TCT 2016 Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR Presenter: Nick Curzen, Michael Mahmoudi October 31, 2016
Presentation TCT 2016 TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo October 31, 2016
Presentation TCT 2016 TCT 44: Independent Mitral Valve Restenosis Predictors After Percutaneous Mitral Balloon Valvuloplasty in a Large, Consecutive Cohort Followed for More Than Two Decades Presenter: Stephan Baldus, Allan Schwartz, Alfredo Nunes Ferreira Neto October 31, 2016
News Conference News TCT 2016 ‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent Todd Neale October 31, 2016
Presentation TCT 2016 Case Presentation: Evaluation and Management of Recurrent DES Restenosis Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla October 30, 2016